title: Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
abstract: Cyclic GMP (cGMP) made in response to atrial natriuretic peptide (ANP) or nitric oxide (NO) is an important regulator of short-term changes in smooth muscle tone and longer-term responses to chronic drug treatment or proliferative signals. The ability of smooth muscle cells (SMCs) to utilize different combinations of phosphodiesterase (PDE) isozymes allows cGMP to mediate these multiple processes. For example, PDE5 as a major cGMP-hydrolyzing PDE effectively controls the development of smooth muscle relaxation. In order for contraction to occur, PDE5 is activated and cGMP falls. Conversely, blockade of PDE5 activity allows the relaxation cycle to be prolonged and enhanced. A recently shown direct activation of PDE5 by cGMP binding to the GAF A domain suggests that this regulatory site might be a target for new drug development. The calcium surge associated with vasoconstrictor initiated contraction also activates a calcium/calmodulin-dependent PDE (PDE1A). Together, PDE5 and PDE1A lower cGMP sufficiently to allow contraction. Longer term, both PDE5 and PDE1A mRNA are induced by chronic stimulation of guanylyl cyclase. This induction is a major cause of the tolerance that develops to NO-releasing drugs. Finally, high levels of cGMP or cAMP also act as a brake to attenuate the proliferative response of SMCs to many mitogens. After vessel damage, in order for SMC proliferation to occur, the levels of cGMP and cAMP must be decreased. In humans, this decrease is caused in large part by induction of another Ca2+/calmodulin-dependent PDE (PDE1C) that allows the brake to be released and proliferation to start.
authors.affiliation: Department of Pharmacology, University of Washington, Seattle, Wash 98195, USA.
authors.forename: Sergei D
authors.initials: SD
authors.lastname: Rybalkin
authors.forename: Chen
authors.initials: C
authors.lastname: Yan
authors.forename: Karin E
authors.initials: KE
authors.lastname: Bornfeldt
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Beavo
mesh_terms: D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D002455:Cell Division / Q000502:physiology; D006152:Cyclic GMP / Q000378:metabolism; D004789:Enzyme Activation; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D005810:Multigene Family / Q000235:genetics; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000502:physiology*
chemical_list: D007527:Isoenzymes; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D006152:Cyclic GMP